|
Glutathione - Your Brain's Master Antioxidant Defense
Free radicals and oxyradicals play an important role in the development and progression of many brain disorders such as brain injury, neurodegenerative disease, schizophrenia and Down syndrome. Glutathione is the brain's master antioxidant and plays an important protective role in the brain. According to Dr. Jimmy Gutman, "The brain is particularly susceptible to free radical attack because it generates more oxidative by-products per gram of tissue than any other organ." Many neurological and psychiatric disease processes are characterized by... abnormalities in glutathion ...
Author: Priya Shah
CLICK HERE TO READ THE REST OF THIS ARTICLE
Here are a few more
sites I've chosen if you'd like to read more and do more research:
Hepatitis C Management
In contrast, relapsers are patients who become HCV RNA-negative by the end of therapy only to redevelop HCV RNA after stopping therapy. Approximately 20% of patients with undetectable viral levels at.
Sickle Cell Disease Corrected In Human Models Using Stem Cell-based Gene Therapy
Sloan-Kettering Cancer Center have devised a novel strategy that uses stem cell-based gene therapy and RNA interference to genetically reverse sickle cell disease (SCD) in human cells. This research.
RNA Therapy - The ALS Association
Email us Print this page (requires Adobe Acrobat Reader) RNA Therapy [Sub topic of Therapies for ALS] Antisense DNA or RNA binds to a specific mRNA and prevents it from being translated into protein.
Gary A. Clawson, M.D., Ph.D.
Of papilloma progression using antisense oligonucleotides targeted to HPV 11 E6/E7 RNA. Gene Therapy, In press, 2004. Pan W-H, Xin P, Morrey JD, Clawson GA. A self-processing ribozyme.
Consensus IFN+ IFN Gamma-1b in African-American Peg Nonresponders
Review of patients treated with PEG IFN-_-2 + RBV who had <2 log10 reduction in HCV RNA (nonresponders). Therapy was switched to a combination of IFN alfacon-1 15 _g administered subcutaneously (SC.
Ind Treat Rebetron
Stopping therapy if the HCV-RNA is detectable at 24 weeks after using a weak dose of interferon is. 12 of 33 patients (36%) are partial responders with a 96% fall in their HCV-RNA during therapy.
Meditation - Color Therapy Meditation
Net Baxamed Medical Center Youth restoration therapies, including hormone replacement therapy, fetal cell therapy, RNA therapy, thymus immune therapy, and chelation therapy. Located in Switzerland.
Link Technologies News Press Releases
One important area of application is in antisense DNA/RNA therapy where conjugates may offer a method of increasing bioavailability in cells and allowing better targeting of antisense molecules.
Alphabetical A-Z Listing of Anti-Aging Medicine
Adenine Dinucleotide N-acetylcarnosine Can-C, Carnosine NeyDent Toothpaste with RNA Cell Therapy NeyGeront RNA Cell Therapy, Placenta NeySkin CoQ10 RNA Moisturizing Cream with Coenzyme.
Early Virological Assessment of Response to Peginterferon Alfa- 2a (Pegasys).
In subjects showing e 2 log reduction in HCV-RNA. Therapy is provided for 6 or 12 months in patients. 10 drop in HCV-RNA) are shown in the table below. Nine patients discontinued therapy due to adverse.
Aging - Health - wolist.com - Everything you want to know about Aging is on.
weeksmd.com [62] Baxamed Medical Center Youth restoration therapies, including hormone replacement therapy, fetal cell therapy, RNA therapy, thymus immune therapy, and chelation therapy. Located in.
|
|
|
